Development and Application of Patient-Derived Models of Cancer

Part of paid clinical trials in Irvine, California.

Sponsor
Certis Oncology Solutions, Inc
Study ID
NCT07226180
Status
Enrolling By Invitation

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this observational study is to evaluate the clinical utility of investigational patient-derived cancer models, to assess the performance of biomarker-based therapeutic predictions in the patient-derived models. Each participant in the observational study will have a piece of cancer removed as part of routine, physician direct care and grown in laboratory mice, where multiple anti-cancer drugs can be tested on it simultaneously. Additional data will be provided to the oncologist; interpretation of the results and any clinical actions are at the sole discretion of the oncologist.

Key Dates

Start date
Dec 11, 2025
Status verified
Mar 2026
Primary completion
Sep 30, 2028
Completion
Sep 30, 2029

Study Design

Enrollment
40 participants (estimated)

Primary Outcome Measure

PDX Tumor Growth [ Time Frame: 180 days ]

Locations (3)

FacilityCityStateZIPSite coordinators
Hoag Hospital IrvineIrvineCalifornia92618-
Hoag Health Center Newport BeachNewport BeachCalifornia92663-
Hoag Memorial Hospital PresbyterianNewport BeachCalifornia92663-

Find similar trials in Irvine, CA

By research site
Hoag Hospital Irvine· Irvine, CAHoag Health Center Newport Beach· Newport Beach, CAHoag Memorial Hospital Presbyterian· Newport Beach, CA

Related Studies